Published in Arthritis Rheum on December 01, 2011
NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis. Sci Transl Med (2013) 3.70
Smoking, Porphyromonas gingivalis and the immune response to citrullinated autoantigens before the clinical onset of rheumatoid arthritis in a Southern European nested case-control study. BMC Musculoskelet Disord (2015) 1.45
Environmental and gene-environment interactions and risk of rheumatoid arthritis. Rheum Dis Clin North Am (2012) 1.26
Porphyromonas gingivalis facilitates the development and progression of destructive arthritis through its unique bacterial peptidylarginine deiminase (PAD). PLoS Pathog (2013) 1.22
Microbiome and mucosal inflammation as extra-articular triggers for rheumatoid arthritis and autoimmunity. Curr Opin Rheumatol (2014) 1.21
The link between periodontal disease and rheumatoid arthritis: an updated review. Curr Rheumatol Rep (2014) 1.20
Periodontal disease and rheumatoid arthritis: the evidence accumulates for complex pathobiologic interactions. Curr Opin Rheumatol (2013) 1.10
Clinical correlations with Porphyromonas gingivalis antibody responses in patients with early rheumatoid arthritis. Arthritis Res Ther (2013) 0.99
Surface α-enolase promotes extracellular matrix degradation and tumor metastasis and represents a new therapeutic target. PLoS One (2013) 0.97
Autoantibodies in systemic autoimmune diseases: specificity and pathogenicity. J Clin Invest (2015) 0.92
Periodontal disease and subgingival microbiota as contributors for rheumatoid arthritis pathogenesis: modifiable risk factors? Curr Opin Rheumatol (2014) 0.90
Rheumatoid arthritis is an autoimmune disease caused by periodontal pathogens. Int J Gen Med (2013) 0.90
Antibiotics for the treatment of rheumatoid arthritis. Int J Gen Med (2013) 0.89
Periodontal disease, Porphyromonas gingivalis, and rheumatoid arthritis: what triggers autoimmunity and clinical disease? Arthritis Res Ther (2013) 0.88
From focal sepsis to periodontal medicine: a century of exploring the role of the oral microbiome in systemic disease. J Physiol (2016) 0.87
Porphyromonas gingivalis and the pathogenesis of rheumatoid arthritis: analysis of various compartments including the synovial tissue. Arthritis Res Ther (2013) 0.86
Blood microbiota dysbiosis is associated with the onset of cardiovascular events in a large general population: the D.E.S.I.R. study. PLoS One (2013) 0.86
A Potential Link between Environmental Triggers and Autoimmunity. Autoimmune Dis (2014) 0.85
How the microbiota shapes rheumatic diseases. Nat Rev Rheumatol (2016) 0.80
Microbial Infection and Rheumatoid Arthritis. J Clin Cell Immunol (2013) 0.80
Association between anti-Porphyromonas gingivalis or anti-α-enolase antibody and severity of periodontitis or rheumatoid arthritis (RA) disease activity in RA. BMC Musculoskelet Disord (2015) 0.79
Human α-enolase is immunogenic, but not arthritogenic, in HLA-DR4-transgenic mice: comment on the article by Kinloch et al. Arthritis Rheum (2012) 0.78
Chronic exposure to oral pathogens and autoimmune reactivity in acute coronary atherothrombosis. Autoimmune Dis (2014) 0.76
Prophylactic Injection of Recombinant Alpha-Enolase Reduces Arthritis Severity in the Collagen-Induced Arthritis Mice Model. PLoS One (2015) 0.76
Soluble alpha-enolase activates monocytes by CD14-dependent TLR4 signalling pathway and exhibits a dual function. Sci Rep (2016) 0.76
Bone loss and aggravated autoimmune arthritis in HLA-DRβ1-bearing humanized mice following oral challenge with Porphyromonas gingivalis. Arthritis Res Ther (2016) 0.75
Immune responses to Mycobacterial heat shock protein 70 accompany self-reactivity to human BiP in rheumatoid arthritis. Sci Rep (2016) 0.75
Subchronic Infection of Porphyromonas gingivalis and Tannerella forsythia Stimulates an Immune Response but Not Arthritis in Experimental Murine Model. Int J Dent (2017) 0.75
The Infectious Basis of ACPA-Positive Rheumatoid Arthritis. Front Microbiol (2017) 0.75
The case for periodontitis in the pathogenesis of rheumatoid arthritis. Nat Rev Rheumatol (2017) 0.75
IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses. Nat Immunol (2011) 5.11
Technologies for global health. Lancet (2012) 5.05
Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule. J Immunol (2003) 4.64
Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis. Immunol Rev (2010) 2.71
Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and α-enolase: implications for autoimmunity in rheumatoid arthritis. Arthritis Rheum (2010) 2.53
Specific interaction between genotype, smoking and autoimmunity to citrullinated alpha-enolase in the etiology of rheumatoid arthritis. Nat Genet (2009) 2.48
Antibodies to citrullinated alpha-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase. Arthritis Rheum (2008) 2.31
The autoantibody repertoire in periodontitis: a role in the induction of autoimmunity to citrullinated proteins in rheumatoid arthritis? Ann Rheum Dis (2013) 2.28
Arthritis induced by posttranslationally modified (citrullinated) fibrinogen in DR4-IE transgenic mice. J Exp Med (2008) 2.17
Identification of citrullinated alpha-enolase as a candidate autoantigen in rheumatoid arthritis. Arthritis Res Ther (2005) 2.02
Periodontitis in RA-the citrullinated enolase connection. Nat Rev Rheumatol (2010) 1.98
Synovial fluid is a site of citrullination of autoantigens in inflammatory arthritis. Arthritis Rheum (2008) 1.86
Analysis of the mitochondrial DNA genome in the peripheral blood leukocytes of HIV-infected patients with or without lipoatrophy. AIDS (2002) 1.55
Serum autoantibodies that bind citrullinated fibrinogen are frequently found in patients with rheumatoid arthritis. J Rheumatol (2006) 1.54
Blockade of tumor necrosis factor in collagen-induced arthritis reveals a novel immunoregulatory pathway for Th1 and Th17 cells. J Exp Med (2008) 1.51
Association of severe inflammatory polyarthritis in primary Sjögren's syndrome: clinical, serologic, and HLA analysis. J Rheumatol (2009) 1.46
Preferential signaling and induction of allergy-promoting lymphokines upon weak stimulation of the high affinity IgE receptor on mast cells. J Exp Med (2003) 1.42
Toll-like receptor 2 ligands on the staphylococcal cell wall downregulate superantigen-induced T cell activation and prevent toxic shock syndrome. Nat Med (2009) 1.29
Insertional polymorphisms: a new lease of life for endogenous retroviruses in human disease. Trends Genet (2007) 1.27
Aberrant IgG galactosylation precedes disease onset, correlates with disease activity, and is prevalent in autoantibodies in rheumatoid arthritis. Arthritis Rheum (2010) 1.25
Porphyromonas gingivalis facilitates the development and progression of destructive arthritis through its unique bacterial peptidylarginine deiminase (PAD). PLoS Pathog (2013) 1.22
Underwater birth: missing the evidence or missing the point? Pediatrics (2003) 1.19
Heightened immune response to autocitrullinated Porphyromonas gingivalis peptidylarginine deiminase: a potential mechanism for breaching immunologic tolerance in rheumatoid arthritis. Ann Rheum Dis (2013) 1.18
Haemophilus ducreyi causing chronic skin ulceration in children visiting Samoa. Clin Infect Dis (2007) 1.18
Family perspectives on pathways to mental health care for children and youth in rural communities. J Rural Health (2006) 1.16
Immune modulation by silencing IL-12 production in dendritic cells using small interfering RNA. J Immunol (2003) 1.11
Interventions for actinic keratoses. Cochrane Database Syst Rev (2012) 1.10
Mouse model of enlarged vestibular aqueducts defines temporal requirement of Slc26a4 expression for hearing acquisition. J Clin Invest (2011) 1.07
Antihomocitrullinated fibrinogen antibodies are specific to rheumatoid arthritis and frequently bind citrullinated proteins/peptides. J Rheumatol (2014) 1.07
Systematic review of nondermatophyte mold onychomycosis: diagnosis, clinical types, epidemiology, and treatment. J Am Acad Dermatol (2011) 1.06
Bacterial and human peptidylarginine deiminases: targets for inhibiting the autoimmune response in rheumatoid arthritis? Arthritis Res Ther (2010) 1.03
The distribution of the endogenous retroviruses HERV-K113 and HERV-K115 in health and disease. Genomics (2005) 1.00
Citrullination of autoantigens: upstream of TNFα in the pathogenesis of rheumatoid arthritis. FEBS Lett (2011) 1.00
Evolutionarily conserved antigens in autoimmune disease: implications for an infective aetiology. Int J Biochem Cell Biol (2008) 0.98
Investigation of susceptibility loci identified in the UK rheumatoid arthritis whole-genome scan in a further series of 217 UK affected sibling pairs. Arthritis Rheum (2004) 0.97
Anti-citrullinated protein antibodies in unaffected first-degree relatives of rheumatoid arthritis patients. Arthritis Rheum (2013) 0.97
Reporter gene assay for the quantification of the activity and neutralizing antibody response to TNFα antagonists. J Immunol Methods (2011) 0.96
Gene disruption by regulated short interfering RNA expression, using a two-adenovirus system. Hum Gene Ther (2004) 0.96
Antibodies to citrullinated α-enolase peptide 1 and clinical and radiological outcomes in rheumatoid arthritis. Ann Rheum Dis (2011) 0.96
The risks of underwater birth. Am J Obstet Gynecol (2004) 0.95
The relationship between predicted peptide-MHC class II affinity and T-cell activation in a HLA-DRbeta1*0401 transgenic mouse model. Arthritis Res Ther (2002) 0.94
A comparison of heparin management strategies in infants undergoing cardiopulmonary bypass. Anesth Analg (2008) 0.87
Pathogenic role of antibodies to citrullinated proteins in rheumatoid arthritis. Expert Rev Clin Immunol (2006) 0.86
Serotyping for an extended anti-citrullinated peptide autoantibody panel does not add value to CCP2 testing for diagnosing RA in an early undifferentiated arthritis cohort. Ann Rheum Dis (2011) 0.85
Negative regulation of the peptidylarginine deiminase type IV promoter by NF-κB in human myeloid cells. Gene (2013) 0.84
Heterogeneity of anticitrullinated peptide antibodies and response to anti-tumor necrosis factor agents in rheumatoid arthritis. J Rheumatol (2012) 0.84
Giving credit where credit is due: John Hunter and the discovery of erythrocyte sedimentation rate. Lancet (2005) 0.83
IL-17 induces hyperalgesia via TNF-dependent neutrophil infiltration. Pain (2011) 0.83
Preventing and curing citrulline-induced autoimmune arthritis in a humanized mouse model using a Th2-polarizing iNKT cell agonist. Immunol Cell Biol (2011) 0.82
Prostaglandin E2 activates HPK1 kinase activity via a PKA-dependent pathway. J Biol Chem (2007) 0.82
Spinal gout in a young patient with involvement of thoracic, lumbar and sacroiliac regions. Joint Bone Spine (2013) 0.81
Inhibiting citrullination in rheumatoid arthritis: taking fuel from the fire. Arthritis Res Ther (2012) 0.81
Induction of transient arthritis by the adoptive transfer of a collagen II specific Th1 clone to HLA-DR4 (B1*0401) transgenic mice. J Autoimmun (2002) 0.80
HERV-K113 is not associated with multiple sclerosis in a large family-based study. AIDS Res Hum Retroviruses (2008) 0.80
Mouse p10, an alternative spliced form of p15INK4b, inhibits cell cycle progression and malignant transformation. Cancer Res (2005) 0.80
The joy of citrulline: new insights into the diagnosis, pathogenesis, and treatment of rheumatoid arthritis. J Rheumatol (2004) 0.79
CTLA-4Ig blocks the development and progression of citrullinated fibrinogen-induced arthritis in DR4-transgenic mice. Arthritis Rheum (2010) 0.79
Mathematical model for pressure losses in the hemodialysis graft vascular circuit. J Biomech Eng (2005) 0.78
The influence of HLA-DR4 (0401) on the immune response to type II collagen and the development of collagen induced arthritis in mice. J Autoimmun (2002) 0.78
Social persuasion in rheumatology: a randomized trial of testimonials on television in the rheumatology clinic waiting room to increase attendance for multidisciplinary education. Rheumatol Int (2014) 0.78
Serum cytokine profile of unaffected first-degree relatives of patients with rheumatoid arthritis. J Rheumatol (2014) 0.77
Monoarthritis in rheumatic fever? Pediatr Infect Dis J (2007) 0.77
Follow-up of MMR vaccination status in children referred to a pediatric immunization clinic on account of egg allergy. Hum Vaccin (2005) 0.76
Raltitrexed (Tomudex): an alternative choice in patients intolerant to 5-fluorouracil. Cancer Invest (2002) 0.76
Epitope spreading in animal models: array of hope in rheumatoid arthritis and multiple sclerosis. Arthritis Res Ther (2008) 0.76
Has the time come for a universal varicella (chicken pox) vaccination in New Zealand? N Z Med J (2010) 0.75
Severe necrotizing pancreatitis following combined hepatitis A and B vaccination. CMAJ (2007) 0.75
Can we rely on anti-citrulline antibody determination for the diagnosis of early rheumatoid arthritis? J Rheumatol (2006) 0.75
Immunisation in hospital--an opportunity repeatedly missed. N Z Med J (2009) 0.75
An intriguing relationship between the immune response to citrullinated vimentin and the HLA shared epitope: comment on the article by Verpoort et al. Arthritis Rheum (2008) 0.75
Children's understanding of illness: students' assessments. J Pediatr Nurs (2002) 0.75
1282: IMPROVING COMPLIANCE RATE FOR THROMBOPROPHYLAXIS IN CRITICALLY ILL ADULTS ADMITTED TO THE PICU. Crit Care Med (2016) 0.75
Implementing empowering health promotion programmes for Aboriginal youth in two distinct communities in British Columbia, Canada. Promot Educ (2005) 0.75
132: FGF-2, VEGF-A AS BIOMARKERS FOR BLEEDING AND FLUID OVERLOAD AFTER PEDIATRIC CARDIOPULMONARY BYPASS. Crit Care Med (2016) 0.75